267 related articles for article (PubMed ID: 14980084)
1. Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.
Inoue Y; Kitagawa M; Onozaki K; Hayashi H
J Interferon Cytokine Res; 2004 Jan; 24(1):43-54. PubMed ID: 14980084
[TBL] [Abstract][Full Text] [Related]
2. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.
Fukuchi M; Imamura T; Chiba T; Ebisawa T; Kawabata M; Tanaka K; Miyazono K
Mol Biol Cell; 2001 May; 12(5):1431-43. PubMed ID: 11359933
[TBL] [Abstract][Full Text] [Related]
3. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-dependent degradation of TGF-beta-activated smad2.
Lo RS; Massagué J
Nat Cell Biol; 1999 Dec; 1(8):472-8. PubMed ID: 10587642
[TBL] [Abstract][Full Text] [Related]
5. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
Stroschein SL; Bonni S; Wrana JL; Luo K
Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
[TBL] [Abstract][Full Text] [Related]
6. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
7. Atrophin-1-interacting protein 4/human Itch is a ubiquitin E3 ligase for human enhancer of filamentation 1 in transforming growth factor-beta signaling pathways.
Feng L; Guedes S; Wang T
J Biol Chem; 2004 Jul; 279(28):29681-90. PubMed ID: 15051726
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
9. A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1.
Liu X; Elia AE; Law SF; Golemis EA; Farley J; Wang T
EMBO J; 2000 Dec; 19(24):6759-69. PubMed ID: 11118211
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.
Ray D; Terao Y; Nimbalkar D; Chu LH; Donzelli M; Tsutsui T; Zou X; Ghosh AK; Varga J; Draetta GF; Kiyokawa H
Mol Cell Biol; 2005 Apr; 25(8):3338-47. PubMed ID: 15798217
[TBL] [Abstract][Full Text] [Related]
11. On and off: proteasome and TGF-beta signaling.
Zhang F; Laiho M
Exp Cell Res; 2003 Dec; 291(2):275-81. PubMed ID: 14644150
[TBL] [Abstract][Full Text] [Related]
12. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
13. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
Lin X; Liang M; Feng XH
J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
15. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
16. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1.
Nourry C; Maksumova L; Pang M; Liu X; Wang T
BMC Cell Biol; 2004 May; 5():20. PubMed ID: 15144564
[TBL] [Abstract][Full Text] [Related]
18. Proteasomal activity modulates TGF-ss signaling in a gene-specific manner.
Zhang F; Mönkkönen M; Roth S; Laiho M
FEBS Lett; 2002 Sep; 527(1-3):58-62. PubMed ID: 12220633
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
20. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]